Kevin E. Weddington

Array ( [id] => 5829259 [patent_doc_number] => 20060063838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Activators of peroxisome proliferator-activated receptors' [patent_app_type] => utility [patent_app_number] => 11/272864 [patent_app_country] => US [patent_app_date] => 2005-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1852 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20060063838.pdf [firstpage_image] =>[orig_patent_app_number] => 11272864 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4860480 [patent_doc_number] => 20080269330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Nutrition Containing Fat Blend' [patent_app_type] => utility [patent_app_number] => 11/666990 [patent_app_country] => US [patent_app_date] => 2005-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3174 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20080269330.pdf [firstpage_image] =>[orig_patent_app_number] => 11666990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4753304 [patent_doc_number] => 20080161379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'Methods of Treating Diabetes Mellitus' [patent_app_type] => utility [patent_app_number] => 11/667224 [patent_app_country] => US [patent_app_date] => 2005-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 9613 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20080161379.pdf [firstpage_image] =>[orig_patent_app_number] => 11667224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5215698 [patent_doc_number] => 20070104779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Treatment with omega-3 fatty acids and products thereof' [patent_app_type] => utility [patent_app_number] => 11/267581 [patent_app_country] => US [patent_app_date] => 2005-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2962 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20070104779.pdf [firstpage_image] =>[orig_patent_app_number] => 11267581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4797951 [patent_doc_number] => 20080009537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-10 [patent_title] => 'Therapeutic Agent for Diabetes Comprising Protease-Inhibiting Compound' [patent_app_type] => utility [patent_app_number] => 11/667099 [patent_app_country] => US [patent_app_date] => 2005-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17557 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20080009537.pdf [firstpage_image] =>[orig_patent_app_number] => 11667099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5711086 [patent_doc_number] => 20060052431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => '5-Hydroxy indazole derivatives for treating glaucoma' [patent_app_type] => utility [patent_app_number] => 11/265029 [patent_app_country] => US [patent_app_date] => 2005-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5431 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20060052431.pdf [firstpage_image] =>[orig_patent_app_number] => 11265029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7966517 [patent_doc_number] => 07939551 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-10 [patent_title] => 'Combination therapeutic compositions' [patent_app_type] => utility [patent_app_number] => 11/258817 [patent_app_country] => US [patent_app_date] => 2005-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 3 [patent_no_of_words] => 12734 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/939/07939551.pdf [firstpage_image] =>[orig_patent_app_number] => 11258817 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5777374 [patent_doc_number] => 20060106014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Methods for treating diabetes' [patent_app_type] => utility [patent_app_number] => 11/251423 [patent_app_country] => US [patent_app_date] => 2005-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11757 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20060106014.pdf [firstpage_image] =>[orig_patent_app_number] => 11251423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5028961 [patent_doc_number] => 20070270408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'Pharmaceutical use of substituted pyrazolo[1,5-a]pyrimidines' [patent_app_type] => utility [patent_app_number] => 11/254118 [patent_app_country] => US [patent_app_date] => 2005-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23394 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20070270408.pdf [firstpage_image] =>[orig_patent_app_number] => 11254118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7810996 [patent_doc_number] => 08133526 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-13 [patent_title] => 'Fat compositions' [patent_app_type] => utility [patent_app_number] => 11/576574 [patent_app_country] => US [patent_app_date] => 2005-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8245 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/133/08133526.pdf [firstpage_image] =>[orig_patent_app_number] => 11576574 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5029030 [patent_doc_number] => 20070270477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'Agent for Prophylaxis or Treatment of Metabolic Syndrome' [patent_app_type] => utility [patent_app_number] => 11/664107 [patent_app_country] => US [patent_app_date] => 2005-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6773 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20070270477.pdf [firstpage_image] =>[orig_patent_app_number] => 11664107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5743648 [patent_doc_number] => 20060089373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'High potency dopaminergic treatment of neurological impairment associated with brain injury' [patent_app_type] => utility [patent_app_number] => 11/240281 [patent_app_country] => US [patent_app_date] => 2005-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16858 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20060089373.pdf [firstpage_image] =>[orig_patent_app_number] => 11240281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5881465 [patent_doc_number] => 20060030548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'Methods of using ryanodine antagonists in treating neural injury' [patent_app_type] => utility [patent_app_number] => 11/241546 [patent_app_country] => US [patent_app_date] => 2005-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3527 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20060030548.pdf [firstpage_image] =>[orig_patent_app_number] => 11241546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 303664 [patent_doc_number] => 07534803 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-19 [patent_title] => 'Method of treating demyelinating diseases or conditions' [patent_app_type] => utility [patent_app_number] => 11/236145 [patent_app_country] => US [patent_app_date] => 2005-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12687 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/534/07534803.pdf [firstpage_image] =>[orig_patent_app_number] => 11236145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5828999 [patent_doc_number] => 20060063738 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/236403 [patent_app_country] => US [patent_app_date] => 2005-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 43921 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20060063738.pdf [firstpage_image] =>[orig_patent_app_number] => 11236403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5045674 [patent_doc_number] => 20070264347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'Agent for Treating or Preventing Diabetic Neuropathy' [patent_app_type] => utility [patent_app_number] => 11/662746 [patent_app_country] => US [patent_app_date] => 2005-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7299 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20070264347.pdf [firstpage_image] =>[orig_patent_app_number] => 11662746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5743649 [patent_doc_number] => 20060089374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease' [patent_app_type] => utility [patent_app_number] => 11/232724 [patent_app_country] => US [patent_app_date] => 2005-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23488 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20060089374.pdf [firstpage_image] =>[orig_patent_app_number] => 11232724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5808338 [patent_doc_number] => 20060094693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Methods and compositions for treating glucose-associated conditions, metabolic syndrome, dyslipidemias and other conditions' [patent_app_type] => utility [patent_app_number] => 11/233532 [patent_app_country] => US [patent_app_date] => 2005-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 30971 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 35 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094693.pdf [firstpage_image] =>[orig_patent_app_number] => 11233532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4574729 [patent_doc_number] => 07829712 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-09 [patent_title] => 'Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase' [patent_app_type] => utility [patent_app_number] => 11/575642 [patent_app_country] => US [patent_app_date] => 2005-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17178 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/829/07829712.pdf [firstpage_image] =>[orig_patent_app_number] => 11575642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4803641 [patent_doc_number] => 20080015230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-17 [patent_title] => 'HETEROCYCLIC DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS' [patent_app_type] => utility [patent_app_number] => 11/575638 [patent_app_country] => US [patent_app_date] => 2005-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16178 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20080015230.pdf [firstpage_image] =>[orig_patent_app_number] => 11575638 [rel_patent_id] =>[rel_patent_doc_number] =>)